R.H. Bluestein & Co’s Aflac AFL Stock Holding History

R.H. Bluestein & Co’s Portfolio AFL Stock Details AFL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-5,000	Closed	-$268K	–	420
2021 Q2	$268K	Hold	5,000	–	–	0.01%	350
2021 Q1	$256K	Sell	5,000 -500	-9%	-$24K	0.01%	353
2020 Q4	$245K	Buy	+5,500	New	+$225K	0.01%	328
2020 Q1	–	Sell	-6,650	Closed	-$352K	–	290
2019 Q4	$352K	Buy	+6,650	New	+$353K	0.02%	236

Other funds holding AFL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JPH

Japan Post Holdings Tokyo, Japan $5.97B AUM 11.18% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

R.H. Bluestein & Co's AFL Position: Q3 2021 in Review

R.H. Bluestein & Co sold out of Aflac (AFL) in Q3 2021, closing a stake of 5,000 shares — an estimated $268K sold.

R.H. Bluestein & Co first reported a position in AFL in Q4 2019 and held it in 4 quarters. The position peaked at $352K in Q4 2019. 1,067 funds tracked by Wall St. Rank hold AFL as of Q3 2021.

R.H. Bluestein & Co reported no remaining Aflac position as of Q3 2021 after selling out during the quarter.
R.H. Bluestein & Co sold 5,000 Aflac shares in Q3 2021, an estimated $268K.
R.H. Bluestein & Co first reported a position in Aflac in Q4 2019 and held it in 4 quarters.
R.H. Bluestein & Co's Aflac position peaked at $352K in Q4 2019.
1,067 funds tracked by Wall St. Rank held Aflac as of Q3 2021.

Based on R.H. Bluestein & Co's 13F filing for Q3 2021, filed 12 Nov 2021.